Enlivex reports positive knee osteoarthritis trial results for Allocetra
Go back to Enlivex reports positive knee osteoarthritis trial results for Allocetra| Enliven Marketing Technologies Corporation (NASDAQ: ENLV) | Delayed: 1.53 +0.02 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.51 | 52 Week High | $0.94 | |||
| Open | $1.51 | 52 Week Low | $0.47 | |||
| Day High | $1.57 | P/E | N/A | |||
| Day Low | $1.47 | EPS | $-0.11 | |||
| Volume | 139,193 | |||||
